Allergan plc
AGN.PRA
AGN.PRA was delisted on the 28th of February, 2018.
108 hedge funds and large institutions have $2.65B invested in Allergan plc in 2016 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 29 increasing their positions, 46 reducing their positions, and 26 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
8% less funds holding
Funds holding: 117 → 108 (-9)
16% less capital invested
Capital invested by funds: $3.14B → $2.65B (-$493M)
35% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 26
37% less repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 46
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$196M |
| 2 |
LCM
Lakewood Capital Management
New York
|
+$45.5M |
| 3 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$40.9M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$36.1M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$27M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$175M |
| 2 |
O
OrbiMed
New York
|
-$66.7M |
| 3 |
Allianz Asset Management
Munich,
Germany
|
-$56.8M |
| 4 |
Calamos Advisors
Naperville,
Illinois
|
-$53.4M |
| 5 |
SC
Sculptor Capital
New York
|
-$31.6M |
AGN.PRA Hedge Fund Activity: Q4 2016 in Review
108 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN.PRA) for Q4 2016, worth a combined $2.65B — down 16% from $3.14B a quarter earlier.
Sellers outnumbered buyers: 26 funds closed out of AGN.PRA and 17 opened new positions — a net loss of 9 holders — while 46 trimmed existing stakes and 29 added.
The largest buyer was Loomis, Sayles & Company, opening a new position worth an estimated $196M. The largest seller was AQR Arbitrage, exiting entirely with an estimated $175M sold.
- 108 institutional investors held Allergan plc (AGN.PRA) as of Q4 2016, down from 117 in Q3 2016.
- Funds reported $2.65B of Allergan plc stock for Q4 2016, down 16% quarter-over-quarter.
- 17 funds opened new Allergan plc positions in Q4 2016 and 26 closed out, a net change of -9 holders.
- The largest Allergan plc buyer in Q4 2016 was Loomis, Sayles & Company, an estimated $196M added.
- The largest Allergan plc seller in Q4 2016 was AQR Arbitrage, an estimated $175M sold.
Based on aggregated 13F filings for Q4 2016.